Omega Fund Management as of Sept. 30, 2020
Portfolio Holdings for Omega Fund Management
Omega Fund Management holds 16 positions in its portfolio as reported in the September 2020 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Replimune Group Common Stock (REPL) | 33.1 | $122M | 5.3M | 22.90 | |
| Morphic Holding Common Stock (MORF) | 22.0 | $81M | 3.0M | 27.34 | |
| Gossamer Bio Common Stock (GOSS) | 11.1 | $41M | 3.3M | 12.41 | |
| Immunic Common Stock (IMUX) | 9.0 | $33M | 1.8M | 18.57 | |
| Arcutis Biothereapeutics Common Stock (ARQT) | 5.2 | $19M | 659k | 29.30 | |
| Checkmate Pharmaceuticals Common Stock | 4.2 | $15M | 1.3M | 11.51 | |
| Paratek Pharmaceuticals Common Stock | 3.8 | $14M | 2.6M | 5.41 | |
| Alpine Immune Sciences Common Stock | 3.1 | $11M | 1.3M | 8.79 | |
| ESSA Pharma Common Stock (EPIX) | 1.6 | $6.1M | 913k | 6.68 | |
| Cidara Therapeutics Common Stock | 1.5 | $5.7M | 2.0M | 2.85 | |
| Trevi Therapeutics Common Stock (TRVI) | 1.5 | $5.5M | 1.4M | 4.03 | |
| FibroGen Common Stock (FGEN) | 1.5 | $5.4M | 131k | 41.12 | |
| Jounce Therapeutics Common Stock | 0.7 | $2.7M | 335k | 8.16 | |
| ObsEva Common Stock | 0.7 | $2.5M | 999k | 2.48 | |
| Prevail Therapeutics Common Stock | 0.5 | $1.9M | 188k | 10.18 | |
| Pieris Pharmaceuticals Common Stock | 0.4 | $1.6M | 751k | 2.07 |
